Table 3 3- and 5-year survival rate and median survival time of the studies included in the meta-analysis
Study | 3-year survival rate (%) | 5-year survival rate (%) | Median survival time (month) | ||||||
|---|---|---|---|---|---|---|---|---|---|
Control | PVR | HAR | Control | PVR | HAR | Control | PVR | HAR | |
Nimura et al. [18] | 40.4 | 18.6 | – | 27.3 | 4.7 | – | 29.0 | 13.4 | – |
Muñoz et al. [19] | 44.4 | 20.0 | – | 38.9 | 20.0 | – | 48.0 | 25.0 | – |
Ebata et al. [9] | 54.1 | 25.5 | – | 36.7 | 10.6 | – | 37.4 | 17.4 | – |
Miyazaki et al. [10] | 39.8 | 17.6 | 11.1 | 29.7 | 14.7 | 0 | 24.0 | 11.2 | 7.0 |
Igami et al. [11] | 56.8 | 37.7 | 37.7 | 51.1 | 33.3 | 22.6 | 64.1 | 22.1 | 19.9 |
Hemming et al. [20] | 52.8 | 54.8 | – | 37.7 | 38.1 | – | 37.7 | 49.7 | – |
de Jong et al. [21] | 37.6 | 37.3 | – | 22.0 | 29.4 | – | 22.9 | 18.8 | – |
Tamoto et al. [14] | 53.8 | 66.7 | – | 53.8 | 58.3 | – | 20.5 | 20.5 | – |
Yu et al. [12] | 27.6 | 20.0 | 19.1 | 21.8 | 0.0 | 6.4 | – | – | – |
Hoffmann et al. [22] | 41.0 | 28.6 | – | 17.9 | 19.0 | – | 28.1 | 32.3 | – |
Wang et al. [15] | 46.5 | 37.5 | 25.0 | 36.0 | 25.0 | 25 | 32.0 | 20 | 26.0 |
Peng et al. [7] | 51.4 | – | 42.3 | 37.1 | – | 30.8 | 49.0 | – | 23.0 |
Nakanishi et al. [23] | 45.9 | 45.7 | – | 21.6 | 25.5 | – | 51.4 | 41 | – |
Noji et al. [24] | 53.6 | – | 35.7 | 26.5 | – | 17.9 | 47.1 | – | 27.7 |
Dumitraşcu et al. [25] | 42 | 28 | – | 43 | 26 | – | 26 | 34 | – |
Schimizzi et al. [13] | 33.3 | 26.3 | 50.0 | – | – | – | 21.0 | 24 | 45.0 |
Mizuno et al. [26] | 62.9 | 38.2 | 49.2 | 50.1 | 24.6 | 29.5 | 60 | 29 | 34 |